Nytheria focuses on measurements that answer relevant questions, support responsible interpretation and help shape meaningful decisions.
A marker earns its place by being useful, interpretable and actionable.
More tests can create more false alarms, incidental findings and conflicting advice. Nytheria’s panel should be broad enough to see patterns and disciplined enough to avoid decorative medicine.
Markers may help describe glucose control, insulin context and lipid metabolism. No value should be interpreted without fasting status, medication, symptoms and clinical history.
ApoB, Lp(a), conventional lipids and blood pressure offer different pieces of cardiovascular information. They are not interchangeable and may trigger medical follow-up.
Inflammatory markers and blood-cell patterns are useful only in context. Temporary illness, exercise, medication and many other factors can change them.
Liver enzymes and kidney-function estimates must be read with age, muscle mass, hydration, medication and medical history.
Hormone testing should answer a relevant question. Age, sex, cycle, symptoms, medication and sampling time can materially affect interpretation.
Selected nutrient markers may help identify deficiency, excess or the need for further assessment. Supplements should not be recommended from a marketing script.
Physical capacity and body composition can show meaningful change that a blood panel alone may miss.
Genetic predisposition and biological-age methods should be selected for a defined purpose, with consent, method limitations and professional interpretation made explicit.
Could the result reasonably influence follow-up, referral, monitoring or a safe change in behaviour?
Is the method sufficiently reliable, standardised and appropriate for the intended use?
Can qualified professionals explain the value, context, uncertainty and limitations clearly?
Is change over time meaningful, or would repeating the test mostly produce expensive noise?
Different biological-age methods may reflect immune and inflammatory patterns, DNA methylation, clinical laboratory combinations or other features. Their outputs are not interchangeable.
Nytheria should explain what the selected method measures, how repeatable it is, which changes are meaningful and what it cannot conclude. The method has not yet been selected.
A signal, not a verdict.
Biological-age results belong beside biomarkers, medical context and physical function, not above them.
Define the biological process and the method, not merely whether the value is green or red.
Consider temporary illness, preparation, medication, exercise, age, sex and individual history.
Act, monitor, repeat, refer or leave alone. “Optimise everything” is not a serious answer.
Set a responsible review pathway and define whether reassessment is useful.
Join early access to receive the confirmed measurement domains, methods and programme options when they are ready.
Apply for early access